Breast cancer
Breast cancer
08/28/2017
The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.
08/28/2017
FDA
FDA
07/18/2017
The US Food and Drug Administration recently approved a new treatment option for patients with early stage HER2-overexpressed/amplified breast cancer. For recommended dosage and common adverse events, read...
07/18/2017
Breast cancer
Breast cancer
05/09/2017
The first combination pack for the treatment of advanced or metastatic breast cancer in postmenopausal women has been approved by the FDA.
05/09/2017
FDA
FDA
04/03/2017
The FDA converted Ibrance to regular FDA approval and approved a supplemental New Drug Application for the drug, broadening its range of antihormonal therapy.
04/03/2017
Breast cancer
Breast cancer
03/14/2017
The FDA approved ribociclib, taken with an aromatase inhibitor, for the treatment of advanced or metastatic breast cancer in post-menopause women.
03/14/2017